These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24321977)

  • 1. Addressing standards of care in resource-limited settings.
    Dawson L; Klingman KL; Marrazzo J
    J Acquir Immune Defic Syndr; 2014 Jan; 65 Suppl 1(0 1):S10-4. PubMed ID: 24321977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensuring participant safety and trial integrity with clinical trials oversight.
    Godfrey C; Payton M; Tasker S; Proestel S; Schouten JT
    J Acquir Immune Defic Syndr; 2014 Jan; 65 Suppl 1(0 1):S40-3. PubMed ID: 24321985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention.
    Dawson L; Zwerski S
    Bioethics; 2015 Jun; 29(5):316-23. PubMed ID: 25230397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical issues raised by cluster randomised trials conducted in low-resource settings: identifying gaps in the
    Mtande TK; Weijer C; Hosseinipour MC; Taljaard M; Matoga M; Goldstein CE; Nyambalo B; Rosenberg NE
    J Med Ethics; 2019 Jun; 45(6):388-393. PubMed ID: 31189724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV prevention research and global inequality: steps towards improved standards of care.
    Shapiro K; Benatar SR
    J Med Ethics; 2005 Jan; 31(1):39-47. PubMed ID: 15634752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing Demand for Universally Improved Health Outcomes with Need for a Local Standard of Care.
    Krudy C; Arora KS
    AMA J Ethics; 2018 Mar; 20(1):261-268. PubMed ID: 29542436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical challenges in international HIV prevention research.
    MacQueen KM; Shapiro K; Karim QA; Sugarman J
    Account Res; 2004; 11(1):49-61. PubMed ID: 15341046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
    Kent DM; Mwamburi M; Cash RA; Rabin TL; Bennish ML
    Am J Bioeth; 2003; 3(2):W11. PubMed ID: 14635629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical considerations in HIV prevention and vaccine research in resource-limited settings.
    Garner SA; Anude CJ; Adams E; Dawson L
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):77-83. PubMed ID: 25117930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory challenges associated with conducting multicountry clinical trials in resource-limited settings.
    Ndebele P; Blanchard-Horan C; Shahkolahi A; Sanne I
    J Acquir Immune Defic Syndr; 2014 Jan; 65 Suppl 1(0 1):S29-31. PubMed ID: 24321981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A capacity-based approach for addressing ancillary care needs: implications for research in resource limited settings.
    Bright PL; Nelson RM
    J Med Ethics; 2012 Nov; 38(11):672-6. PubMed ID: 22562947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions.
    Angelidou K; Fowler MG; Flynn P; Coletti A; McCarthy K; Browning R; McIntyre J; Brummel SS; Shapiro DE; Tierney C;
    Clin Trials; 2020 Aug; 17(4):437-447. PubMed ID: 32191142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical issues in adolescent HIV research in resource-limited countries.
    Bekker LG; Slack C; Lee S; Shah S; Kapogiannis B
    J Acquir Immune Defic Syndr; 2014 Jan; 65 Suppl 1():S24-8. PubMed ID: 24321980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the ethical and regulatory issues in pragmatic clinical trials.
    Califf RM; Sugarman J
    Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The highest attainable standard: ethical issues in AIDS vaccines.
    Bloom BR
    Science; 1998 Jan; 279(5348):186-8. PubMed ID: 9446225
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethical complexities of conducting research in developing countries.
    Varmus H; Satcher D
    N Engl J Med; 1997 Oct; 337(14):1003-5. PubMed ID: 9309109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Vaccine Trial participation in South Africa - an ethical assessment.
    Moodley K
    J Med Philos; 2002 Apr; 27(2):197-215. PubMed ID: 11961697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conflicts among multinational ethical and scientific standards for clinical trials of therapeutic interventions.
    Kolman JM; Wray NP; Ashton CM; Wenner DM; Jarman AF; Brody BA
    J Law Med Ethics; 2012; 40(1):99-121. PubMed ID: 22458466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.